Irvine’s Masimo Gets $10 Million Boost
- Share via
Masimo Corp., an Irvine medical technology company, said it has received a $10 million infusion from Franklin Templeton Investments.
The funds will be used primarily to step up production to meet higher than expected demand for the company’s Radical Signal Extraction pulse oximeter, which measures blood-oxygen levels and pulse rates through the skin.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
